Therapeutic Advances in Musculoskeletal Disease

Papers
(The H4-Index of Therapeutic Advances in Musculoskeletal Disease is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge91
Pathophysiology of musculoskeletal pain: a narrative review62
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis51
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of43
Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways42
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review42
Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders34
Opportunistic diagnosis of osteoporosis, fragile bone strength and vertebral fractures from routine CT scans; a review of approved technology systems and pathways to implementation31
Comparative effectiveness of treatment options for subacromial shoulder conditions: a systematic review and network meta-analysis29
A warning machine learning algorithm for early knee osteoarthritis structural progressor patient screening29
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)27
Moving toward targeting the right phenotype with the right platelet-rich plasma (PRP) formulation for knee osteoarthritis27
Biomarkers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review26
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders26
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies26
Body composition in patients with rheumatoid arthritis: a narrative literature review26
Large-vessel involvement is predictive of multiple relapses in giant cell arteritis25
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?23
Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus22
A broad look into the future of rheumatoid arthritis21
Ultrasound for diagnosis and follow-up of chronic axillary vasculitis in patients with long-standing giant cell arteritis20
Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica – a prospective cohort study20
0.030694007873535